If you would like to join the team at ProQR but you can't find the right job opening at this moment, you are welcome to send us an open application via our connect portal!
Find all relevant presentations and publications for each of our programs. From review papers to preclinical posters and clinical data presentations at medical conferences.
At ProQR science is literally at the heart of what we do. Our passion lies in discovering the latest RNA technologies and translating them to life-changing treatments.
ProQR is pioneering a next-generation RNA technology called Axiomer™, which uses a cell’s own editing machinery called ADAR to make specific single nucleotide edits in RNA to reverse a mutation or modulate protein expression and could potentially yield a new class of medicines for both rare and prevalent diseases with unmet need.
At ProQR, our mission is to edit RNA, treat disease and change lives. This guides every decision we make as we work to develop new treatment options for people living with high unmet need.
Our vision is to create a world where genetics informs your health - but never limit it. By harnessing the power of RNA editing, we strive to make our vision for the future a reality.
At ProQR, we are dedicated to improving the lives of patients and families affected by rare and common disorders using Axiomer, our innovative RNA editing platform technology.
Find out how ProQR’s stock is trading now and in the past. Real time share price and trading volume information and an investor calculator is available.
This website contains forward-looking statements about potential therapeutic uses and effects of ProQR Therapeutics’ products, including but not limited to our technologies.
